Skip to main content

Table 2 Incidence of disease recurrence and deaths according to the detection of CK-19 mRNA-positive circulating tumor cells

From: Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse

CK-19 mRNA

No of patients

Relapses

 

Deaths

 
  

Yes

N (%)

No

N (%)

Fisher's Exact test, P

Dead

N (%)

Alive

N (%)

Fisher's Exact test, P

Persistently Positive

99

36 (36.4)

63 (63.6)

P < 0.001

24 (24.2)

75 (75.8)

P = 0.001

Persistently Negative

80

9 (11.2)

71 (88.8)

 

5(6.3)

75 (93.8)

 

Positive Turn to negative

64

5 (7.8)

59 (92.2)

P < 0.001

versus persistently positive

3 (4.7)

61 (95.3)

P = 0.001

versus persistently positive

Negative Turn to positive

69

13 (18.8)

56 (81.2)

P = 0.016

versus persistently positive

9 (13.0)

60 (87.0)

P = 0.079

versus persistently positive

  1. While also,
  2. P = .248 for relapse of turn to positive versus persistently negative
  3. P = .172 for deaths of turn to positive versus persistently negative
  4. CK-19, cytokeratine-19.